Related Experiment Video
Updated: Jul 15, 2026
04:29
Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
Vagus nerve stimulation: treatment modality for epilepsy
Björn D Krapohl1, Maria Deutinger, Fercan Kömürcü
1Department of Plastic and Reconstructive Surgery, Military and Governmental Hospital, University of Berlin Charité, Berlin, Germany.
Medsurg Nursing : Official Journal of the Academy of Medical-Surgical Nurses
|April 20, 2007
Summary
Vagal nerve stimulation offers an alternative treatment for epilepsy when anticonvulsant medications are insufficient. This method can reduce seizure frequency and intensity, enhancing patient quality of life.
Area of Science:
- Neurology
- Neurosurgery
- Biomedical Engineering
Background:
- Epilepsy treatment primarily relies on anticonvulsant medications.
- A subset of patients exhibit insufficient response to pharmacological therapies.
- Alternative interventions are crucial for managing refractory epilepsy.
Purpose of the Study:
- To evaluate the efficacy of vagal nerve stimulation (VNS) in patients with epilepsy.
- To assess the impact of VNS on seizure control and quality of life.
- To describe the outcomes of VNS implantation procedures.
Main Methods:
- Series of vagus nerve stimulator implantations performed.
- Patient outcomes related to seizure frequency and intensity were monitored.
- Quality of life metrics were assessed post-implantation.
Main Results:
- Vagal nerve stimulation demonstrated potential in reducing seizure frequency.
- VNS implantation led to a decrease in seizure intensity for some patients.
- Improvements in patients' quality of life were observed.
Conclusions:
- Vagal nerve stimulation is a viable therapeutic option for drug-resistant epilepsy.
- Implantable electrical nerve stimulators can effectively manage epilepsy symptoms.
- VNS offers a promising adjunctive therapy for epilepsy management.
Related Concept Videos
01:24Epilepsy and Seizures: Overview
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
01:30Electroconvulsive Therapy
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
01:13Seizures: Classification
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
01:22Epilepsy ll: Types
Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.